Upotate fled. C t r . , Svracnsc. N.Y.
I n t r a t h e c a l nethotrexnte and r r a n i a l i r r a d i a t i o n a r e uaed a s prophvlactic therapv i n children w i t h ALL. This rejzimen i s r e c o g n i z~d t o producp undesirable s i d e e f f e c t s . Tn a r a t t r n p t t c monitor t h e poosible i n l u r f c u s e f f r c t s of these agents, n t e s t wao developed f c r t h e rrcasurrment of s p i n a l f l u i d TA (Ped. Res. 19:?7h, 1076) . I n 1' l p a t i e n t s (6 mos. t o 16 y r a . ) , s p i n a l f l u i d TA was measured s e q u e n t f a l l v from t h e time of d i a g n r a i s . I n i t t a l TA v s s s i m i l a r t o t h a t of age matched c o n t r o l s . Curing C11R prophylaxis a s i g n i f i c a n t increase i n TA !,as observed, f r o r an i n i t i a l nean of l A X * 7.5(SD) t o 37.5" 11.5. 3/19 l a t e r developed t h e p o s t -i r r a d i a t i o n smdrone. A c t i v i t v i n these 3 was s i g n i f i c n r . t l y higher (57.77't 7.6) than t h e remainder of t h e group (3?..87+ 7.6). TA was a l s o measured f n an a d d i t i o n a l 32 p a t i e n t s with ALL. The nean r e s u l t s c f a l l p a t i e n t s studied a r e l i s t e d below.
*I -?-la y m .
16.1 ( 9 ) 36.1 (14) 31.5 (13) Although i t is r e c o~n i s e d t h a t v i t u i n E deficiency may be ansociated with a hemolytic anemia i n premature i n f a n t s a t 6 t o 10 weeks of s~s , no i n f o r n a
t i o n is a v a i l a b l e t o i n d i c a t e i f t h e v i t u i n E deficiency normally preaent a t b i r t h h a s h e m a t o l o~i c consequences.
A study was desipned to determine i f t h e pres m c e o f v i t u i n E d e f i c i e n c y d u r i n~ the f i r s t week of l i f e played a c o n t r i b u t o r y r o l e i n t h e shortened red c e l l l i f e s p a n observed i n the premature i n f a n t . Carboxyhemoglobin values w r e used a s an index of hemolysis. Ten healthy, pretenn i n f a n t s received intramuscular vitamin E i n a t o t a l dose of 125 m p /~g during days 3 t o 7 of l i f e and t e n i n f a n t s served a s cont r o l s . The percent carboxyhemo~lobin l e v e l s f e l l s i~n i f i c a n t l y from day 3 t o day 8 i n t h e t r e a t e d p,roup (1.09% t o 0.78:) while t h e w a n value remained unchanged a t 0.96): i n t h e c o n t r o l group.
The a d m i n i s t r a t i o n of vitamin E during t h e f i r s t week of l i f e appears t o reduce, but not eliminate, t h e a c c e l e r a t e d red c e l l d e s t r u c t i o n t h a t is c h a r a c t e r i s t i c of t h e premature in£ ant.

HYPERVISCOSITY I N THE SMALL-FOR-GESTATIONAL AGE
INFANT. David 0. Hakanson, and William Oh. Brown University Program i n Medicine, Woman and I n f a n t s Hospital o f R.I., Department of P e d i a t r i c s , Providence, R.I.
SGA i n f a n t s a r e prone t o hyperviscosity but t h e p r e c i s e i n c idence i s unknown. A prospective survey was conducted on 4,794 consecutive l i v e b i r t h f o r hyperviscosity i n SGA i n f a n t s . SGA i s defined a s b i r t h weight below t h e 10th p e r c e n t i l e of i n t r a u t e ri n e growth curve and s i g n s of m a l n u t r i t i o n ; and hyperviscosity a s venous blood v i s c o s i t y (measured by micro-viscometer) above t h e 2 S.D. of t h e norm, 79 i n f a n t s vere i d e n t i f i e d a s SGA and of t h e s e , 14 were hyperviscous (HV) and 65 were normal viscous (NV). The venous hematocrit range from 64-70% i n HV and 37-62% f o r NV. A pre-defined symptom complex r e f e r a b l e t o cardiovascular, res p i r a t o r y , g a s t r o i n t e s t i n a l , and c e n t r a l nervous systems were assessed by 2 unbiased observers; 57% of HV and 25% of NV inf a n t s were symptomatic (p<.05 by Chi square). The d a t a i n d i c a t e d t h a t H V occur i n 17.7% of SGA i n f a n t s ; venous hematocrit (>64%) is p r e d i c t i v e of W ; and t h a t i n s p i t e of a p o s i t i v e c o r r e l a t i o n between symptom complex and HV, t h e r e i s a lack o f s p e c i f i c i t y f o r t h e c l i n i c a l manifestation of HV. In Iron deficiency anemia (FeDA) and lead l n t o x l c a t l o n ( P b l ) t h e f lnal s t e p In heme s y n t h e s i s Is deranged In such o manner t h a t p r o t o p o r p h y r l~ (PP) accumulates wl t h i n t h e red blood c e l Is.
A Zlnc-PP c h e l a t e (ZnPP) Is t h e primary s p e c i e s o f PP present in these condltlons. By f l u o r e s c e n t s p e c t r a w e have found some f r e e (unchelated) PP In addltion t o ZnPP In t h e rbcs o f c h i l d r e n with FeDA and Pbl.
In f a c t , In one chi Id with a c u t e FeDA t h e prodomlnant s p e c l e s present was f r e e PP, and t h l s PP was changed to
ZnPP during t h e course o f treatment. Sequential s t u d l e s of leadpolsoned r a t s show t h a t PP In t h e peripheral blood increases rapldiy (wlthln a week o f exposure) and t h a t l n l t l a l l y f r e e PP Is
